KYTHERA BIOPHARMACEUTICALS INC

Inactive Instrument

Kythera Biopharmaceuticals Inc Stock

Equities

US5015701056

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015

Allergan : forecasts second-half revenue above $8 billion

RE

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Latest news about Kythera Biopharmaceuticals Inc

Allergan : forecasts second-half revenue above $8 billion

15-09-28

RE

Press releases Kythera Biopharmaceuticals Inc

Kythera Biopharmaceuticals : Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin	15-10-08	PU
Kythera Biopharmaceuticals : ® Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss	15-10-08	PU
KYTHERA(R) Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss	15-09-22	GL
KYTHERA(R) Biopharmaceuticals Submits Marketing Authorization Application in the European Union for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat	15-08-18	GL
KYTHERA Biopharmaceuticals Releases Second Quarter 2015 Operating Results and Progress Update	15-08-06	GL

More press releases

News in other languages on Kythera Biopharmaceuticals Inc

Allergan : Rassurée par la Fed, Wall Street finit dans le vert	15-06-17
Wall Street attendue en timide hausse avant la Fed	15-06-17
Adobe Systems : Les valeurs à suivre à Wall Street	15-06-17
Allergan : achète la biotech Kythera pour 2,1 milliards de dollars	15-06-17

Managers and Directors - Kythera Biopharmaceuticals Inc

Managers	Title	Age	Since
Ambrose Bailey PSD	President	60	15-09-30
Maria Hilado BRD	Director/Board Member	59	15-09-30
Jere D. Fellmann PRN	Corporate Officer/Principal	72	12-05-31

Members of the board	Title	Age	Since
Maria Hilado BRD	Director/Board Member	59	15-09-30
Ambrose Bailey PSD	President	60	15-09-30
Steven Fagien BRD	Director/Board Member	-	-

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+2.93%	108B
ARGENX SE	+7.02%	23.46B
BIONTECH SE	-14.60%	21.72B
GENMAB A/S	-7.05%	18.64B
WUXI APPTEC CO., LTD.	-38.55%	17.45B
BEIGENE, LTD.	-8.83%	17.19B
NEUROCRINE BIOSCIENCES, INC.	+5.51%	13.99B
SAREPTA THERAPEUTICS, INC.	+37.49%	12.53B
VIKING THERAPEUTICS, INC.	+329.39%	8.81B

Bio Therapeutic Drugs

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW